Matthew Miner is currently the Senior Director of QC Bioanalytics at Cellares, having started in 2024. Previously, they held the position of Vice President of Global Quality Control at NOVAVAX INC from 2022 to 2024 and served as the Head of Quality Control at Novartis between 2018 and 2022. With extensive experience in microbiology, they were the Director of QC Microbiology at Eli Lilly and Company from 2010 to 2018, and have worked with notable companies such as GlaxoWellcome and Burroughs Wellcome earlier in their career. Matthew earned a Bachelor of Science degree in Biology from East Carolina University from 1989 to 1994.
This person is not in any teams
This person is not in any offices